Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina.
Cancer Res. 2020 Nov 15;80(22):4972-4985. doi: 10.1158/0008-5472.CAN-20-1162. Epub 2020 Sep 25.
Lung squamous carcinoma (LUSC) is a highly metastatic disease with a poor prognosis. Using an integrated screening approach, we found that miR-671-5p reduces LUSC metastasis by inhibiting a circular RNA (circRNA), CDR1as. Although the putative function of circRNA is through miRNA sponging, we found that miR-671-5p more potently silenced an axis of CDR1as and its antisense transcript, cerebellar degeneration related protein 1 (CDR1). Silencing of CDR1as or CDR1 significantly inhibited LUSC metastases and CDR1 was sufficient to promote migration and metastases. CDR1, which directly interacted with adaptor protein 1 (AP1) complex subunits and coatomer protein I (COPI) proteins, no longer promoted migration upon blockade of Golgi trafficking. Therapeutic inhibition of the CDR1as/CDR1 axis with miR-671-5p mimics reduced metastasis . This report demonstrates a novel role for CDR1 in promoting metastasis and Golgi trafficking. These findings reveal an miRNA/circRNA axis that regulates LUSC metastases through a previously unstudied protein, CDR1. SIGNIFICANCE: This study shows that circRNA, CDR1as, promotes lung squamous migration, metastasis, and Golgi trafficking through its complimentary transcript, CDR1.
肺鳞癌(LUSC)是一种转移性很高且预后不良的疾病。通过综合筛选方法,我们发现 miR-671-5p 通过抑制环状 RNA(circRNA)CDR1as 来减少 LUSC 转移。虽然 circRNA 的假定功能是通过 miRNA 海绵作用,但我们发现 miR-671-5p 更能沉默 CDR1as 及其反义转录物小脑退化相关蛋白 1(CDR1)的轴。沉默 CDR1as 或 CDR1 显著抑制 LUSC 转移,CDR1 足以促进迁移和转移。直接与衔接蛋白 1(AP1)复合物亚基和衣壳蛋白 I(COPI)蛋白相互作用的 CDR1,在阻断高尔基体运输后不再促进迁移。用 miR-671-5p 模拟物抑制 CDR1as/CDR1 轴的治疗性抑制减少了转移。本报告证明了 CDR1 在促进转移和高尔基体运输中的新作用。这些发现揭示了一种 miRNA/circRNA 轴,通过以前未研究过的蛋白 CDR1 来调节 LUSC 转移。意义:这项研究表明 circRNA、CDR1as 通过其互补转录物 CDR1 促进肺鳞状细胞的迁移、转移和高尔基体运输。